A Study to Assess the Effect of Intragastric pH and Fasting on the Pharmacokinetics of Gefapixant (AF-219/MK-7264)
Clinical trial NCT02229877 · COMPLETED
Trial details
- NCT number
- NCT02229877
- Sponsor
- Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-06
- Primary completion
- 2015-05-14
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.